NCT06219187

Brief Summary

This is a non-interventional, prospective, single-center study designed to collect and describe environmental and psychosocial data from patients with a history of male breast cancer (MBC) referenced in the IUCT-O regional database. The study will be conducted on a population of 110 to 150 patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
93

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 12, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 23, 2024

Completed
16 days until next milestone

Study Start

First participant enrolled

February 8, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 6, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 6, 2025

Completed
Last Updated

February 20, 2025

Status Verified

February 1, 2025

Enrollment Period

12 months

First QC Date

January 12, 2024

Last Update Submit

February 18, 2025

Conditions

Keywords

Breast CancerPreDisposition factor

Outcome Measures

Primary Outcomes (2)

  • The environmental data in the questionnaire will be described by the usual descriptive statistics.

    A 75-question questionnaire will cover such aspects as the patient's living conditions, professional situation, qualifications or level of education, social environment, early life and family environment, general health and recent significant events. Quantitative data will be described by the median, minimum, maximum and number of missing data, and qualitative data by the numbers, percentages and number of missing data for each modality.

    15 days for each patient

  • Psychosocial data from the questionnaire will be described using standard descriptive statistics.

    A 75-question questionnaire will cover such aspects as the patient's living conditions, professional situation, qualifications or level of education, social environment, early life and family environment, general health and recent significant events. Quantitative data will be described by the median, minimum, maximum and number of missing data, and qualitative data by the numbers, percentages and number of missing data for each modality.

    15 days for each patient

Study Arms (1)

Male breast cancer

Other: Questionnaire completion

Interventions

To meet the study's objective, patients will be asked to complete a questionnaire characterizing their environmental and psychosocial context. The questionnaire is to be completed by the patients themselves, or by their trusted support person as recorded in their medical records (in the particular case of a deceased patient). It is estimated that the questionnaire will take around 30 minutes to complete. Data will also be collected from the medical records of included patients: * Demographics * Disease data

Male breast cancer

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with a history of male breast cancer (MBC) referenced in the IUCT-O's regional MutaFamily-MBC database.

You may qualify if:

  • Male patient with a personal history of breast cancer
  • Age ≥ 18 years
  • Patient who has had an oncogenetic consultation at IUCT-O and is registered in the IUCT-O oncogenetic database
  • Patient for whom no pathogenic variant has been detected on the HBOC panel (HBOC-)
  • Patient with no objection to participation in the trial (for deceased patients: trusted support person with no objection to participation).

You may not qualify if:

  • \. Patient who has forfeited his/her freedom by administrative or legal award or who is under legal protection (curatorship and guardianship, protection of justice).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IUCT-O

Toulouse, France

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 12, 2024

First Posted

January 23, 2024

Study Start

February 8, 2024

Primary Completion

February 6, 2025

Study Completion

February 6, 2025

Last Updated

February 20, 2025

Record last verified: 2025-02

Locations